Companies › PULM
Pulmatrix Inc (PULM)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001574235 · EDGAR filings · Updated 2026-07-09
Pulmatrix Inc (PULM) has reported institutional ownership of 9.0%, with 15 institutional managers holding positions valued at $425.1K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-09 — S-4 filed
- 2026-06-16 — 10-K/A filed
- 2026-06-05 — 425 filed
- 2026-06-04 — Shelf registration (S-3) filed
- 2026-05-15 — Quarterly report (10-Q) filed
- 2026-05-15 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Pulmatrix Inc has 15 institutional holders and institutional ownership of 9.0%.
Data flags from SEC filings
Related companies
CADRENAL THERAPEUTICS INC (CVKD) · XENETIC BIOSCIENCES INC (XBIO) · PROCESSA PHARMACEUTICALS INC (PCSA) · ENDRA LIFE SCIENCES INC (NDRA) · POLYRIZON LTD (PLRZ) · Scienture Holdings Inc (SCNX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.